Hormaeche C E, Mastroeni P, Harrison J A, Demarco de Hormaeche R, Svenson S, Stocker B A
Department of Microbiology, Medical School, University of Newcastle, UK.
Vaccine. 1996 Mar;14(4):251-9. doi: 10.1016/0264-410x(95)00249-z.
The role of the main LPS O antigen in the specificity of protection as mediated by systemic mechanisms following immunization with live attenuated Aro Salmonella vaccines was studied in mice. Innately Salmonella-susceptible (Itys) BALB/c mice were immunized intravenously with a single dose of either Salmonella typhimurium SL3261 aroA (LPS O4,5,12) or Salmonella enteritidis Se795aroA (LPS O1,9,12), and challenged orally 2-3 months later with either S. typhimurium C5 or S. enteritidis Thirsk. Nearly isogenic transductants of the two challenge strains expressing either their own LPS or that of the other serotype (S. typhimurium C5 O4 or O9, and S. enteritidis Thirsk O9 or O4) were also used. Both vaccines conferred similar high protection against the virulent strain of the homologous serotype expressing its own LPS. There was no protection against the heterologous serotype expressing its own LPS. However, when vaccinated mice were challenged with either the same serotype as the vaccine but expressing the heterologous LPS, or with the heterologous serotype expressing the LPS of the vaccine, protection was always lower than protection against the fully homologous serotype. Anti-smooth LPS antibodies showed higher titres against the homologous LPS, but with significant crossreactivity with the heterologous LPS. Antibodies to O-rough S. typhimurium and S. enteritidis LPS were present following immunization with either of the two vaccine strains. The LPS alone cannot fully account for the specificity of protection in this model; other (protein) antigens may be responsible. It remains to be seen whether there is a T-cell mediated component to the specificity of protection conferred by live Salmonella vaccines.
在小鼠中研究了主要脂多糖O抗原在减毒活Aro沙门氏菌疫苗免疫后由全身机制介导的保护特异性中的作用。天生对沙门氏菌易感(Itys)的BALB/c小鼠静脉内单次注射鼠伤寒沙门氏菌SL3261 aroA(脂多糖O4,5,12)或肠炎沙门氏菌Se795aroA(脂多糖O1,9,12),并在2-3个月后口服用鼠伤寒沙门氏菌C5或肠炎沙门氏菌Thirsk进行攻毒。还使用了两种攻毒株的近等基因转导子,它们表达自身的脂多糖或另一种血清型的脂多糖(鼠伤寒沙门氏菌C5 O4或O9,以及肠炎沙门氏菌Thirsk O9或O4)。两种疫苗对表达自身脂多糖的同源血清型的强毒株都提供了相似的高保护。对表达自身脂多糖的异源血清型没有保护作用。然而,当用与疫苗相同血清型但表达异源脂多糖的菌株,或用表达疫苗脂多糖的异源血清型对免疫小鼠进行攻毒时,保护作用总是低于对完全同源血清型的保护。抗光滑脂多糖抗体对同源脂多糖的滴度更高,但与异源脂多糖有显著的交叉反应性。用两种疫苗株中的任何一种免疫后,都存在针对O-粗糙型鼠伤寒沙门氏菌和肠炎沙门氏菌脂多糖的抗体。在该模型中,仅脂多糖不能完全解释保护的特异性;其他(蛋白质)抗原可能起作用。减毒活沙门氏菌疫苗所赋予的保护特异性是否存在T细胞介导的成分还有待观察。